Capital World Investors’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-335,500
Closed -$4.94M 556
2022
Q2
$4.94M Sell
335,500
-2,611,000
-89% -$53.8M ﹤0.01% 506
2022
Q1
$73.1M Buy
2,946,500
+192,000
+7% +$4.96M 0.01% 385
2021
Q4
$88.3M Hold
2,754,500
0.01% 381
2021
Q3
$99.1M Buy
2,754,500
+204,000
+8% +$8.03M 0.02% 375
2021
Q2
$113M Buy
2,550,500
+1,490,500
+141% +$64.9M 0.02% 373
2021
Q1
$48.5M Buy
1,060,000
+380,570
+56% +$21.8M 0.01% 441
2020
Q4
$46.9M Buy
+679,430
New +$33.3M 0.01% 414

Other funds holding LUNG

Capital World Investors's LUNG Position: Q3 2022 in Review

Capital World Investors sold out of Pulmonx (LUNG) in Q3 2022, closing a stake of 335,500 shares — an estimated $4.94M sold.

Capital World Investors first reported a position in LUNG in Q4 2020 and held it in 7 quarters. The position peaked at $113M in Q2 2021. 104 funds tracked by Wall St. Rank hold LUNG as of Q3 2022.

  • Capital World Investors reported no remaining Pulmonx position as of Q3 2022 after selling out during the quarter.
  • Capital World Investors sold 335,500 Pulmonx shares in Q3 2022, an estimated $4.94M.
  • Capital World Investors first reported a position in Pulmonx in Q4 2020 and held it in 7 quarters.
  • Capital World Investors's Pulmonx position peaked at $113M in Q2 2021.
  • 104 funds tracked by Wall St. Rank held Pulmonx as of Q3 2022.

Based on Capital World Investors's 13F filing for Q3 2022, filed 14 Nov 2022.